default author photo

Hironori Yamada

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

38

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Phase II trial of gemcitabine plus nab-paclitaxel–based chemoradiotherapy for locally advanced pancreatic cancer (NUPAT-05): Survival outcomes and feasibility of conversion surgery

Number of pages: 23 Posted: 11 Mar 2026
Hironori Yamada, Haruyoshi Tanaka, Suguru Yamada, Hideki Takami, Masamichi Hayashi, Nobuhiko Nakagawa, Keisuke Kurimoto, Yoshikuni Inokawa, Nobuyuki Watanabe, Takuya Ishikawa, Masayuki Okumura, Hiroshi Ogawa, Masahiko Ando, Osamu Maeda, Junpei Yamaguchi, Shinji Naganawa, Hiroki Kawashima, Tsutomu Fujii, Yukihiro Yokoyama, Tomoki Ebata and Mitsuro Kanda
affiliation not provided to SSRN, affiliation not provided to SSRN, Nagoya University, Nagoya University, Nagoya University, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagoya University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagoya University, Nagoya University - Nagoya University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toyama - Department of Surgery and Science, affiliation not provided to SSRN, Nagoya University - Graduate School of Medicine and affiliation not provided to SSRN
Downloads 38 (1,277,121)

Abstract:

Loading...

pancreatic cancer, locally advanced, conversion surgery, chemoradiotherapy, gemcitabine, nab-paclitaxel